Alloy Therapeutics Inc. (“Alloy”), a biotechnology ecosystem company dedicated to democratizing access to cutting-edge drug discovery technologies, announces the acquisition of Spannerwerks, LLC, a Seattle-based professional services firm that guides biopharmaceutical companies on the development and launch of new products. Founded in 2015, Spannerwerks has built a strong reputation as a trusted partner for pharma and biotech companies, helping them advance toward the clinic through a robust, cost-effective and operationally focused approach to drug development.
Read the full article: Alloy Therapeutics Announces Acquisition of Spannerwerks, a Leading Provider of Drug Development Consulting Services //
Source: https://www.businesswire.com/news/home/20251023321305/en/Alloy-Therapeutics-Announces-Acquisition-of-Spannerwerks-a-Leading-Provider-of-Drug-Development-Consulting-Services